| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4023966 | Journal Français d'Ophtalmologie | 2012 | 9 Pages |
Abstract
Intravitreal ranibizumab injection appears to be safe and effective for treatment of idiopathic macular CNV in young patients. A longer-term prospective trial is required to corroborate these results.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
O. Ouhadj, N. Degheb, S. Idir, A. Nebab, M.T. Nouri,